Sibutramine Health Risks Will Limit Drug's Use: Meridia Cardiovascular Side Effects Evoke Obesity Drug Label Upgrade
Links shared publicly online about this topic.
- 1,424total visits
Sibutramine Health Risks Will Limit Drug's Use: Meridia Cardiovascular Side Effects Evoke Obesity Drug Label Upgrade
Sibutramine health risks revealed by SCOUT study evoke FDA safety review. Raised cardiovascular side effects for obesity drug force Meridia label upgrade for heart risk.
View full resource at weightloss.suite101.com
Tags: Heart, Obesity, Obesity Medication, Drug, FDA
Most Recently Shared on January 28, 2010 at 10:23 am By:
Sibutramine Health Risks Will Limit Drug's Use: Sibutramine health risks revealed by the SCOUT study evoke FDA saf... http://bit.ly/brq8wU
Advertisement
